Naheed Ismaili Misfeldt
Director/Board Member at Visionary Therapeutics Corp.
Profile
Ms. Misfeldt joined Aberdare Ventures from Bay City Capital, a leading life sciences merchant bank.
At Bay City Capital, she evaluated numerous investment opportunities in biopharmaceuticals and assisted portfolio companies in their fundraising activities.
She was also heavily involved in transforming a molecular diagnostics initiative into a new private company focused on providing clinical trials testing and assay development services to pharmaceutical partners.
Prior to Bay City Capital, Ms. Misfeldt served as an Associate in the Healthcare Group at Chase H&Q, where she was involved in numerous advisory and capital raising activities for the bank’s publicly traded and privately held clients.
Since joining Aberdare in early 2003, Ms. Misfeldt has played an instrumental role in new investments in Idun, Avera Pharmaceuticals, and Ruxton Pharmaceuticals.
In addition to assuming oversight responsibilities for these companies, Ms. Misfeldt has been actively involved with Anacor, Microbia, Salmedix, and Pharmion at various times.
Ms. Misfeldt received her BA from UC Berkeley and her MPH from Columbia University.
She is also a member of the Kauffman Fellows Program, Class 9.
Naheed Ismaili Misfeldt active positions
Companies | Position | Start |
---|---|---|
Visionary Therapeutics Corp.
Visionary Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Visionary Therapeutics Corp. develops ocular therapeutics for eye diseases. The company was founded by Steve Hutcherson and is headquartered in Richmond, VA | Director/Board Member | - |
Former positions of Naheed Ismaili Misfeldt
Companies | Position | End |
---|---|---|
Bay City Capital LLC
Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Private Equity Investor | 2002-12-30 |
HemaQuest Pharmaceuticals, Inc.
HemaQuest Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology HemaQuest Pharmaceuticals, Inc. develops small molecule therapeutics. Its products include hydroxyurea, a therapeutic agent for the treatment of underlying pathology of sickle cell anemia and for the treatments of beta thalassemia, sickle cell anemia, neutropenia, and various hematological disorders. The company was founded by Ronald J. Berenson, Douglas V. Faller, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos and Robert Williams in October 2007 and is headquartered in San Diego, CA. | Director/Board Member | - |
Chase H&Q | Corporate Officer/Principal | - |
Aberdare Ventures
Aberdare Ventures Investment ManagersFinance Aberdare Management Co. LLC (Aberdare Ventures) is a venture capital firm founded in 1999 by Paul H. Klingenstein. The firm is headquartered in San Francisco, California. | Private Equity Investor | - |
Training of Naheed Ismaili Misfeldt
The Trustees of Columbia University in The City of New York | Graduate Degree |
University of California, Berkeley | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 5 |
---|---|
Aberdare Ventures
Aberdare Ventures Investment ManagersFinance Aberdare Management Co. LLC (Aberdare Ventures) is a venture capital firm founded in 1999 by Paul H. Klingenstein. The firm is headquartered in San Francisco, California. | Finance |
Chase H&Q | Finance |
Bay City Capital LLC
Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Finance |
HemaQuest Pharmaceuticals, Inc.
HemaQuest Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology HemaQuest Pharmaceuticals, Inc. develops small molecule therapeutics. Its products include hydroxyurea, a therapeutic agent for the treatment of underlying pathology of sickle cell anemia and for the treatments of beta thalassemia, sickle cell anemia, neutropenia, and various hematological disorders. The company was founded by Ronald J. Berenson, Douglas V. Faller, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos and Robert Williams in October 2007 and is headquartered in San Diego, CA. | Health Technology |
Visionary Therapeutics Corp.
Visionary Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Visionary Therapeutics Corp. develops ocular therapeutics for eye diseases. The company was founded by Steve Hutcherson and is headquartered in Richmond, VA | Health Technology |
- Stock Market
- Insiders
- Naheed Ismaili Misfeldt